Arzeda
PrivateLast Round
Grant
Sep 8, 2025
Total Funding Raised
$62.55M
Company Overview
Arzeda is a biotechnology company that leverages AI-driven protein design to create innovative designer proteins and enzymes for industrial, food, and pharmaceutical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arzeda Comparables
Compare Arzeda with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomatter | 80% | |
| Evozyne | 78% | |
| Protera Biosciences | 76% |
Arzeda Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 8, 2025 | ||||
| Grant | Sep 8, 2025 | ||||
| VC Round | Sep 17, 2024 | ||||
| Series B | Mar 30, 2022 | ||||
| Corporate Funding | Nov 24, 2020 | ||||
Series A | Nov 28, 2017 |
Key People
Founding team and executive leadership
Arzeda Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bunge Ventures | Series B, VC Round |
| Fall Line Capital | VC Round |
| Sucden Ventures | VC Round |
| WRF Capital | Series A |
| Conti Ventures | Series B |
| Universal Materials Incubator | Series B, Series A |
| Lewis & Clark Partners | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Launched ViaLeaf Reb M, a revolutionary process using Nobel Prize-winning technology.
- Mar 5, 2026
Partnering on the new ViaLeaf Reb M process.
Recent news
Latest coverage and updates
- partners_withJul 16, 2026
Arzeda partnered with Mane Inc. on Jul 16th '26.
- hiresJun 23, 2026
Arzeda Corp. hired Alex Patist as Chief Operating Officer on Jun 23rd '26.
- hiresJun 23, 2026
Arzeda Corp. hired Paula Hicks as Chief Technology Officer on Jun 23rd '26.
Arzeda Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arzeda's valuation, stock price, and market status.
Is Arzeda a public or private company?
Arzeda is a private company.
What is the current stock price of Arzeda?
Arzeda is a private company with no public stock price. No recent secondary market data is available.
How much is Arzeda worth (valuation)?
Valuation information for Arzeda is not publicly available.
Can I buy Arzeda stock?
Arzeda shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arzeda's last funding round?
Arzeda's most recent funding round was Grant on September 8, 2025.
Who are the main investors in Arzeda?
Key investors in Arzeda include Conti Ventures, OS Fund, Sofinnova Partners, Continental Grain Company, National Science Foundation.
Will Arzeda IPO soon?
No public IPO plans have been announced for Arzeda.
How can I track Arzeda secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arzeda's secondary market activity and sign up for updates.